Companies: 10,795·Total market cap: $144.5T
Roche Holding AG

Roche Holding AG

RHHBYOTCHealthcare● Active
$50.32
$-1.13(-2.20%)
Market Cap$324.1B
P/E Ratio—
52W High$60.85
52W Low$37.51
Shares OutstandingFinancialsRevenue

Roche Holding AG (RHHBY) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

RHHBY · shares outstanding · updated Jun 8, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
6.423B▲ +0.73% YoY Change
FY · as of Dec 31, 2025 · Reported in CHF
vs 6.376B in FY 2024
Diluted Shares Outstanding
6.424B
incl. options, RSUs, convertibles
Dilution Spread
+0.02%
Diluted vs Basic
YoY Change
+0.73%
year-over-year
Float (Free Float)
652.9M
publicly tradable shares
10.1% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-08

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+0.1%
2022 → 2025
5-Year CAGRdeclining
-1.3%
2020 → 2025
10-Year CAGRdeclining
-0.6%
2015 → 2025
ⓘ

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2025Latest
Diluted Shares: 6.424B
6.423B
+0.73%
FY 2024
Diluted Shares: 6.416B
6.376B
-0.25%
FY 2023
Diluted Shares: 6.432B
6.392B
-0.13%
FY 2022
Diluted Shares: 6.400B
6.400B
-5.88%
FY 2021
Diluted Shares: 6.880B
6.800B
-0.58%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs RHHBY
#1
Roche Holding AGRHHBY
Roche Holding AGYOU
6.423B—
#2
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B-61.0%
#3
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B-62.2%
#4
AbbVie Inc.ABBV
AbbVie Inc.
1.780B-72.3%
#5
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B-75.9%
#6
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M-85.8%
#7
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M-86.0%

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

Roche Holding AG (RHHBY) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of December 31, 2025, Roche Holding AG reports 6.423B basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

Roche Holding AG's basic shares outstanding (6.423B) represents currently issued shares. Diluted shares outstanding (6.424B) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.02%.

Shares Outstanding vs. Float (Free Float)

Roche Holding AG's float is 652.9M (10.1% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float652.9M(10.1%)
Outstanding6.441B

ⓘ Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · CHF

About shares outstanding & methodology

Roche Holding AG (RHHBY) shares outstanding history from 2006 to 2025. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

Roche Holding AG shares outstanding for the fiscal year ending December 31, 2025 were 6.423B, a 0.73% increase year-over-year. Roche Holding AG FY 2025 shares outstanding were 6.423B, a +0.73% increase from FY 2024.

Roche Holding AG is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of -0.6% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.
Market capSplitsEarningsFinancials (Income)Cash on handFree cash flowNet incomePrice history

Frequently asked questions

RHHBY shares outstanding · 4 questions

As of December 31, 2025, Roche Holding AG (RHHBY) has approximately 6.423B basic shares outstanding and 6.424B diluted shares outstanding. This represents a +0.73% year-over-year increase from FY 2024 (6.376B). The increase may reflect equity compensation issuances or secondary offerings.

RHHBY shares outstandinghow many shares does RHHBY haveRHHBY basic shares 2025RHHBY diluted shares

▸ Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · Roche Holding AG SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-08